Current Investment Opportunities for Accredited Investors

SAN FRANCISCO - April 9, 2026 - PRLog -- Astro Health Inc., a Delaware C-Corporation based in San Francisco, is an AI-powered digital health company developing Astro X, a multi-agent, 360-degree platform focused on stress and burnout prevention, substance use disorder management, and dementia care support. The platform has been clinically and engineering validated, with pilot programs underway at Los Angeles General Medical Center and academic collaboration with Indiana University.

The company is offering 1,777,778 shares at an IPO-style listing price of $4.50 per share, targeting a raise of $8 million at a pre-money valuation of $32 million. An independent valuation by TAG Investment Bankers places the central equity value at approximately $67 million. Astro Health operates a B2B SaaS and outcomes-based revenue model, targeting employers, insurers, and healthcare systems. Its patent-pending technology is designed to expand into additional care pathways, including dementia and Parkinson's disease.

In parallel, Evrensel Longevity Centers is developing a global network of premium, medically supervised longevity and preventive healthcare centers. Designed as a scalable health platform rather than a single-location clinic, Evrensel plans to launch flagship centers and expand through owned locations and strategic partnerships across major international markets.

The business model includes recurring membership revenues, high-margin medical procedures, and ancillary product offerings. The flagship "108 Center" concept is intended for global replication, targeting affluent, health-conscious consumers seeking advanced diagnostics, longevity protocols, IV therapy, hormone modulation, and regenerative care solutions.

Shares issued under the IPSO (Initial Private Share Offering) structure will be subject to a standard lock-up period, with potential eligibility for trading on regulated U.S. Alternative Trading Systems (ATS) after one year, subject to agreement between the issuer and trading venue.

This communication is for informational purposes only and does not constitute an offer to sell or solicitation to buy securities. Investments are available only to accredited investors and involve risk, including possible loss of capital. Prospective investors should review all offering documents and consult professional advisors before making investment decisions.

Home (https://twex.exchange/)Bulletin Board (https://twex.exchange/bulletin_board)Contact (mailto:info@tagcapgroup.com)